These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: [The utilisation of the leukocyte migration inhibition test (L.M.T) in carcinoma of cervix uteri (author's transl)].
    Author: Schmeisser G, Kademann J.
    Journal: Arch Geschwulstforsch; 1980; 50(2):169-72. PubMed ID: 7436701.
    Abstract:
    The leukocyte migration inhibition test (L.M.T.) was utilized for in vitro studies of cell mediated immunity in gynecologic malignomas. Autogenous peripheral blood leukocytes from 50 patients with a carcinoma of the cervix uteri were studied in about 100 tests. There was found an inhibition of the migration of the autogenous leukocytes in 25 of 47 tests of patients with a CCI without evidence of metastasis or widespread disease. However, the migration of autogenous leukocytes from patients with metastasis or widespread disease (CCII) were only inhibited in 14 of 46 cases. At normal tissue were inhibited in 15 of 89 cases the migration of the autogenous leukocytes.
    [Abstract] [Full Text] [Related] [New Search]